Skip to main content

Netherlands

22
Sep 2021

Results of research for the assessment of medical innovations’ value at an early phase of development in the Netherlands

In August 2021, the Dutch Healthcare Institute (ZIN) published the results of research for the assessment of the value of medical innovations at an early phase of development. The Radboud university medical center was commissioned by the ZIN to investigate this question based on a case study for Anatomy Projector. The objective of the research was to answer the question of how the value of medical innovation is explored and expressed in an early phase, i.e., before market access.
27
Aug 2021

Genetic test Oncotype DX® in early-stage breast cancer will be covered under basic health insurance in the Netherlands

On August 11, 2021, the Dutch Healthcare Institute (ZIN) published the assessment of Oncotype DX®. The assessment was conducted to confirm whether the test complies with the criteria of "science and practice" to determine if it can be reimbursed under the basic health insurance package. In conclusion, the test can be reimbursed under the basic health insurance package.
02
Jun 2021

Dutch Healthcare Institute position on the reimbursement of molecular diagnostics in oncology

In mid-May 2021, the Dutch Healthcare Institute (ZIN) published an advice "Molecular Diagnostics: determining the position on molecular diagnostics in oncology," which was developed at the request of the Ministry of Health, Welfare and Sport. The objective of the position is to organize molecular diagnostics within standard regular care and develop a framework for the accessibility and integral implementation of new tests in practice.
29
Apr 2021

Dutch Healthcare Institute published an annual report on the progress of the conditional reimbursement program in 2020

On April 20, 2021, the Dutch Healthcare Institute (ZIN) published an annual report on the progress of the conditional reimbursement program. In 2020, there were 13 ongoing projects under the program, six of which concerned medical technologies. Furthermore, in 2020, percutaneous transforaminal endoscopic discectomy for the treatment of lumbosacral radicular syndrome in lumbar disc herniation was included in the basic insurance package as regular care.
15
Apr 2021

Five projects awarded under the 2021 "Subsidy scheme for promising care" in the Netherlands

On March 30, 2020, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced five projects which received a subsidy under the "Subsidy scheme for promising care" in 2021: repetitive transcranial magnetic stimulation and in vivo exposure with response prevention in obsessive-compulsive disorder; MRI-guided laser-induced thermotherapy in glioblastoma; personalized treatment with selective internal radiotherapy in elderly or vulnerable colon cancer patients with liver metastases; structured, multidisciplinary and person-centered intensive care aftercare for patients at risk of health problems; Basophil Activation Test in children with possible IgE mediated cow's milk allergy.
18
Mar 2021

A novel approach for upscaling innovations in digital care in the Netherlands

The Dutch Healthcare Institute (ZIN), in collaboration with the Ministry of Health, Welfare and Sport (VWS), Dutch Health Authority (NZa), and Health and Youth Care Inspectorate (IGJ), implemented an extension of existing digital healthcare innovation programs called "ZorgZandbak" to demonstrate how digital care could become an integral part of regular care.